News
A study, which was published in The New England Journal of Medicine, found that tirzepatide (Zepbound) is more effective for ...
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Long Islanders, doctors and industry experts weigh in on medicines like Ozempic and Wegovy — how they work, what they ...
Those who take tirzepatide, the drug sold as Zepbound and Mounjaro, could lose more weight than those who take semaglutide, known as Ozempic and Wegovy, according to new research.
Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as reducing waist circumference, citing data from a head-to-head trial.
The report also underscored the importance of maintaining muscle mass and bone density while losing weight. Since weight loss ...
Drugmakers are offering the blockbuster medications at steep discounts to people willing to pay out of pocket.
Share on Pinterest Tirzepatide (Zepbound) led to more weight loss than semaglutide (Wegovy) in a clinical trial funded by Eli Lilly. Shelby Knowles/Bloomberg/Getty Images Zepbound outperformed ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results